New requirements for clinical testing of vaccines, announced this month, may delay the availability of shots that had ...

Another Breakthrough Summit West in the books, and what an excellent event! We kicked off the day with former FDA head Robert ...

The U.S. Department of Health and Human Services is reportedly planning to nix recommendations for pregnant women, teens, and ...

The U.S. Department of Health and Human Services is planning to drop recommendations for routine COVID-19 vaccines for ...

The Trump administration is planning to drop recommendations that pregnant women, teenagers and children get Covid-19 ...

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...

This was the stock's second consecutive day of losses.

Shares of Novavax Inc. NVAX shed 2.37% to $6.19 Tuesday, on what proved to be an all-around mixed trading session for the ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

An FDA committee will soon make recommendations about this fall’s Covid-19 vaccines while Novavax still awaits full FDA ...